MONDAY, 23 JULY: Ending the Epidemic: Turning the Tide
Anthony S. Fauci, the National Institute of Allergy and Infectious Diseases (NIAID), United States
Ending the HIV Epidemic: From Scientific Advances to Public Health Implementation
Anthony S. Fauci is Director of the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH). Since his appointment as NIAID Director in 1984, Dr. Fauci has overseen an extensive research portfolio devoted to preventing, diagnosing and treating infectious and immune-mediated diseases. He is also Chief of the NIAID Laboratory of Immunoregulation, where he has made numerous important discoveries related to HIV and AIDS and is one of the most-cited scientists in the field. Dr. Fauci, a member of the U.S. National Academy of Sciences, has received numerous awards for his scientific accomplishments, including the National Medal of Science, the Mary Woodard Lasker Award for Public Service and the Presidential Medal of Freedom. He has received 34 honorary doctoral degrees and is the author, coauthor or editor of more than 1,200 scientific publications, including several major textbooks.
Phill Wilson, Black AIDS Institute, United States
Deciding Moment: Ending the AIDS Epidemic in America Together
Phill Wilson is President and CEO of the Black AIDS Institute, the only national HIV/AIDS think tank in the United States focused exclusively on ending the AIDS pandemic in Black communities by engaging and mobilizing Black institutions and individuals in efforts to confront HIV, by interpreting public and private sector HIV policies, conducting trainings, providing technical assistance, and disseminating HIV/AIDS-related information and advocacy from a uniquely and unapologetically Black point of view. Wilson previously served as AIDS Coordinator for the City of Los Angeles, Director of Policy and Planning at AIDS Project L.A., co-chair of the Los Angeles County HIV Health Commission, and appointee to the HRSA AIDS Advisory Committee.
Wilson was involved in the founding of several AIDS service and community-based organizations, including the National Black Lesbian and Gay Leadership Forum, the National Task Force on AIDS Prevention, the Chris Brownlie Hospice, the AIDS Healthcare Foundation, the National Minority AIDS Council, the Los Angeles County Gay Men of Color Consortium, and the CAEAR Coalition. Mr. Wilson has also worked extensively on HIV/AIDS issues in Eastern and Western Europe, sub-Saharan Africa, India and Mexico. He was named by the Ford Foundation one of the 20 award recipients for the Leadership for a Changing World (2001) and received the Discovery Health Channel Medical Honor in 2004. He was also named one of the '2005 Black History Makers in the Making' by Black Entertainment Television. Mr. Wilson has published articles in a variety of leading newspapers and magazines.
Sheila Tlou, UNAIDS
Turning the Tide in Affected Countries: Leadership, Accountability and Targets
Sheila D. Tlou is the Director of the UNAIDS Regional Support Team for Eastern and Southern Africa and the UN Eminent Person for Women, Girls, and HIV/AIDS in Southern Africa. She has been involved in the response to HIV and AIDS from the time the epidemic started in Botswana. As a former Member of Parliament and Minister of Health in Botswana, she led a successful national HIV and AIDS prevention, treatment, care and support programme. As Chairperson of the Southern Africa Development Community (SADC) and African Union Ministers of Health in 2005/6, she provided leadership in adopting the SADC Malaria Eradication Program, the SADC HIV/AIDS Plan of Action, and the Maputo Plan of Action on Sexual and Reproductive Health and Rights. She founded the Botswana chapter of the Society of Women and AIDS in Africa and represented Eastern and Southern Africa on the Board of the Global Fund. Dr. Tlou is a former Professor of Nursing at the University of Botswana and a former Director of the WHO Collaborating Centre for Nursing and Midwifery Development in Primary Health Care for Anglophone Africa. Dr Tlou has received several awards, including the Botswana Presidential Order of Honour, the Florence Nightingale Award from the International Red Cross Society and the Trailblazer Woman Leading Change Award from the World YWCA.
TUESDAY, 24 JULY: Challenges and Solutions
Javier Martinez-Picado, AIDS Research Institute IrsiCaixa and ICREA, Spain
Viral Eradication: The Cure Agenda
Javier Martinez-Picado is ICREA Research Professor at the AIDS Research Institute (IrsiCaixa) in Barcelona, an institution that works to advance clinical research and translate results into patients care. He received his PhD from the University of Barcelona where he subsequently became associated professor lecturing on different microbiology-related subjects. In 1996, he joined the Massachusetts General Hospital as postdoctoral fellow of Harvard Medical School, where he engaged in AIDS research. In 2000, he obtained a position as biomedical researcher of the Spanish Health Department appointed to the Hospital "Germans Trias i Pujol" in Badalona (Barcelona). The research programmes he is leading focus on understanding how HIV causes disease in recently infected people, exploring the best antiretroviral treatment strategies, fighting drug resistance, and collaborating on global HIV/AIDS vaccine development projects. Dr. Martinez- Picado serves on different government, academic and industry advisory boards and has published extensively on HIV treatment strategies and HIV pathogenesis in international journals.
Nelly Mugo, University of Nairobi and Kenyatta National Hospital, Kenya
Implementation Science: Making the New Prevention Revolution Real
Dr. Nelly Mugo is a research scientist and Obstetrician Gynaecologist at the Kenyatta National Referral Hospital, Kenya. She has worked on two multisite HIV-1 prevention clinical trials, as a regional director for the Partners in Prevention HSV/HIV Transmission study and site investigator for the Partners PrEP study, sponsored through the International Clinical Research Center (ICRC), Department of Global Health, and University of Washington. She is currently the head of research and programs at Kenyatta National Hospital.
Bernhard Schwartländer, UNAIDS
What Will It Take to Turn the Tide?
Dr. Bernhard Schwartländer currently holds the position of Director for Evidence, Innovation and Policy at UNAIDS. He took up this position in May 2010 when he joined UNAIDS at headquarters in Geneva from his assignment as the United Nations Country Coordinator on AIDS in Beijing, China. Prior to these assignments, he held a number of senior international positions including as the Director for Performance Evaluation and Policy at the Global Fund to Fight AIDS, Tuberculosis and Malaria, Director of the World Health Organization's HIV Department, and as the Director of Evaluation and Strategic Information at UNAIDS. Before joining the United Nations, Dr. Schwartländer was the Director of the national AIDS programme in Germany and the Director of the Division of Infectious Disease Epidemiology at the Robert Koch-Institut in Berlin, the central biomedical and infectious disease research and reference laboratory of the federal Ministry of Health, Germany. Dr. Schwartländer has published widely in scientific journals and books and taught applied epidemiology in Berlin. He received his education and professional training in Germany and the U.S. at the Centers for Disease Control and Prevention.
WEDNESDAY, 25 JULY: Turning the Tide on Transmission
Barton Haynes, Duke Human Vaccine Institute, United States
The Way Forward For Development of an HIV-1 Vaccine
Barton Haynes is the Frederic M. Hanes Professor of Medicine and Immunology at the Duke University School of Medicine and the Director of the Duke Human Vaccine Institute, where his teams of investigators are working on vaccines for emerging infections including HIV-1, TB and pandemic influenza. He has been the Director of the NIAID-funded Center for HIV/AIDS Vaccine Immunology (CHAVI), a consortium of six universities and academic medical centres that develop and test new vaccine strategies to overcome key immunological roadblocks in HIV vaccine design. Furthermore, Dr. Haynes leads the Haynes Vaccine Discovery Consortia as part of the Collaboration for AIDS Vaccine Discovery (CAVD) funded by the Bill and Melinda Gates Foundation. Dr. Haynes is a member of the Institute of Medicine of the National Academy of Sciences, a Fellow of the American Academy of Arts and Sciences and Fellow of the Infectious Diseases Society of America. He received his MD from Baylor College of Medicine in 1973.
Chewe Luo, UNICEF
Turning the Tide for Children and Youth
Chewe Luo is a paediatrician and tropical child health specialist from Zambia and has over 15 years of experience in both HIV research and programming. She is currently working with UNICEF in New York as a senior programme adviser and global technical leader for scaling up country-wide HIV/AIDS programmes with a focus on PMTCT, paediatric care and treatment, prevention of HIV in adolescents, and protection of affected children. She previously worked as a UNICEF regional PMTCT adviser for Eastern and Southern Africa in Nairobi, providing technical guidance to countries in policy and strategy formulation as well as programme design and as the UNICEF HIV officer in Botswana at a time when Botswana government was rapidly scaling up its PMTCT programme. Before joining UNICEF, Dr. Luo worked as a paediatrician in Zambia and the United Kingdom. Dr. Luo holds a degree in Medicine and postgraduate training in Paediatrics from the Zambia School of Medicine and a Masters and PhD in Tropical Child Health and Epidemiology from the University of Liverpool, United Kingdom.
Linda H. Scruggs, A Woman Diagnosed with AIDS, United States
Making Women Count: A Comprehensive Agenda
Linda H. Scruggs is a wife and a mother of three and serves as a Minister in her local church. Since receiving her HIV diagnosis in 1990 she has supported women, communities and organizations to dream, imagine and serve. Linda believes that through collaborative partnerships and community engagements we can enhance, rebuild, and restore individuals, organizations and governments in promoting healthy communities. Recently, Linda has bridged a partnership with AIDS United, working on strengthening and growing grantmaking and policy work on women's health. She served as the Director of Programs, for AIDS Alliance for Children, Youth & Families in Washington, D.C. (2004-2012). During her time there, she started the Consumer Corps Leadership Training Program, which has been recognized as the national model for HIV consumer empowerment, education, and training. Mrs Scruggs's leadership and commitment to Women and HIV has been recognized nationally and international through speaking engagements, educational programmes, and news articles. In July 2010 Linda received an Honorable Mention by President Barack Obama. Simply stated by Linda 'I'm living a transformed and blessed life with an AIDS diagnosis'. In 2010 she received a Master's of Human Services from Lincoln University, Lincoln, Pennsylvania.
Geeta Rao Gupta, UNICEF
Turning the Tide for Women and Girls
Geeta Rao Gupta is Deputy Executive Director, Programmes at UNICEF. Prior to her appointment, she served as a senior fellow at the Bill and Melinda Gates Foundation where she acted as the senior advisor to the Global Development Programme on the strategic direction and management of a cross-cutting range of issues and projects. From 1996 to 2010, Dr. Rao Gupta was the president of the International Centre for Research on Women (ICRW) where she conducted and oversaw research on topics ranging from the social and economic factors that affect women's use of maternal nutrition and health care services, to girls' and women's vulnerability to HIV. Under her leadership, the ICRW catalyzed policy and programmatic change for women and children around the globe. Dr. Rao Gupta has led and participated in numerous global initiatives for women and children, including the U.N. Millennium Project's Task Force on Education and Gender Equality and is the recipient of various awards, including the 2007 Washington Business Journal's "Women Who Mean Business" Award. She earned a Ph.D. in Social Psychology from Bangalore University and an M.Phil. and M.A. from the University of Delhi, India.
THURSDAY, 26 JULY: Dynamics of the Epidemic in Context
Paul Semugoma, Global Forum on MSM and HIV, Uganda
Turning the Tide for MSM and HIV
Paul Semugoma is a medical doctor, trained in Tanzania and working in Uganda where he is involved in delivery of services for LGBTI, in advocacy to address the gaps in HIV prevention and sexuality education, and in education and building capacity for sexual minorities both nationally and regionally. Dr. Semugoma first became aware of the challenging gaps in HIV Prevention amongst Sexual Minorities in Africa in 2004. He subsequently became involved in efforts to address these gaps and was immediately confronted by the stumbling blocks of ignorance and prejudice. In 2009, he took part in the campaign to challenge the Anti-Homosexuality Bill in Uganda, with emphasis on the predicted effects on health and HIV prevention service delivery. He is currently a member of the Steering Committee of the Global Forum for HIV and MSM (MSMGF), a board member of African Men for Sexual Health and Rights (AMSHeR) and of AFYA Minorité in East Africa.
Cheryl Overs, Monash University, Australia
The Tide Cannot Be Turned without Us: HIV Epidemics amongst Key Affected Populations
Cheryl Overs founded a sex worker organisation which pioneered harm reduction, rights advocacy and peer education in Melbourne in the early eighties. When HIV was identified, she served as advisor to the Global Programme on Aids before establishing the Global Network of Sex Work Projects in 1992. Since then she has worked in HIV policy and programming for male, female and transgender sex workers in more than twenty developing countries. Cheryl is Senior Research Fellow at the Michael Kirby Centre for Public Health and Human Rights at Monash University in Melbourne and a Visiting Fellow at the Institute of Development Studies UK. She is also a member of the Technical Advisory Group of the Global Commission on HIV and the Law. Her current work includes supervising an on-line resource centre on sex work, a study of the impact of law on sex workers and establishing a community legal service for sex workers in Cambodia. As well as academic publications, Cheryl has written several key resources on sex work and HIV, including 'Understanding Sex Work' (2005); 'Sex Work and the New Era of HIV Prevention and Care' (2008); and 'Only Rights Can Stop the Wrongs' (2010).
Debbie McMillan, Transgender Health Empowerment, United States
Making Waves: The Changing Tide of HIV and Drug Use
Debbie McMillan is a 42-year-old transgender woman born and raised in Washington D.C. where she was educated in D.C. Public Schools. Debbie is currently employed with Transgender Health Empowerment as CRCS Specialist and Wellness center coordinator where her responsibilities are to engage high-risk individuals who are at risk for infection or transmission of HIV and other STD, to develop individual prevention plan, and to counsel and connect them with medical care and social services. Before joining Transgender Health Empowerment Ms. McMillan worked with HIPS as Client Advocate and Diversion Specialist, where her main responsibility was first response to various crisis situations. During this time, she began working with commercial sex workers who were involved in the criminal justice system.
Ms. McMillan is a former sex worker and drug user. She is now studying for her undergraduate degree at the University of the District of Columbia where she sits on the Dean's list and is a member of the Honor Society. Passionate about her work in the field of HIV, Ms. McMillan deeply cares about the issues that African American transgender women face. She enjoys spending time with family and those closest to her. She loves to read and swim.
Gottfried Hirnschall, WHO
Expanding Testing and Treatment
Gottfried Hirnschall is the Director of the HIV/AIDS Department of the World Health Organization. In this role, he leads the organization's work in development and implementation of cutting-edge normative policies and guidance for HIV prevention, treatment, care and support. Over the past twenty years, Dr. Hirnschall has contributed to WHO's work in child, adolescent, reproductive health, and HIV, supporting numerous programmes worldwide to change realities for millions of people in need of quality health services. Dr. Hirnschall has managed several major initiatives at WHO, including the mobilization of global partners and donors for the historic «3 by 5» initiative for scaling up HIV treatment in developing countries. He also directed the Caribbean HIV programme for the Pan-American Health Organization (PAHO), and subsequently lead WHO's HIV work for the Americas.
Dr. Hirnschall completed the Epidemic Intelligence Service at the Centers for Disease Control and Prevention (CDC) in Atlanta, USA. As an MD specialized in Family Health at the University of Vienna, Dr. Hirnschall holds a Diploma in Tropical Medicine from the Swiss Tropical and Public Health Institute. He has a Master's degree in Public Health from the Johns Hopkins School of Public Health.
FRIDAY, 27 JULY: HIV in the Larger Global Health Context
Anthony Harries, International Union Against Tuberculosis and Lung Disease, France
TB and HIV: Science and Implementation to Turn the Tide on TB
Anthony Harries is Senior Advisor at the International Union against Tuberculosis and Lung Disease in Paris and honorary professor at the London School of Hygiene and Tropical Medicine. He is a physician and a registered specialist in infectious diseases and tropical medicine. His main interests are in the field of tuberculosis, HIV/AIDS, tropical medicine and operational research. Dr. Harries spent over 20 years living and working in sub-Saharan Africa, starting in North-east Nigeria in 1983. In 1986, he moved to Malawi where he was consecutively Consultant Physician, Foundation Professor of Medicine at the new medical school in Blantyre, National Advisor to the Malawi Tuberculosis Control Programme and National Advisor in HIV care and treatment in the Ministry of Health, responsible for scaling up antiretroviral therapy in the country. In 2008, he returned to UK and took his current position as Senior Advisor with The Union. In 2009, he was also appointed Director of the new Department of Research, which comprises the Centre for Operational Research, Health Policy Unit and Clinical Trials Unit.
Dr. Harries has received several awards and prizes for his work, and in 2002 was appointed Officer of the Order of the British Empire (OBE) for services to work in tuberculosis in Africa.
Judith Currier, University of California, Los Angeles, United States
Intersection of Non-Communicable Diseases and Ageing in HIV
Judith Currier is Professor of Medicine, Chief, Division of Infectious Diseases and Co Director of the Center for AIDS Research and Education Center (CARE) at the University of California, Los Angeles (UCLA). She is Vice Chair of the NIH sponsored AIDS Clinical Trials Group and is currently the Principal Investigator of the UCLA AIDS Prevention and Treatment Clinical Trials Unit in Los Angeles. The unit includes four sites in Los Angeles and is involved in community based HIV prevention, HIV vaccine research and therapeutic clinical trials. Her research is focused on understanding the factors that contribute to long-term complications of HIV disease and HIV treatments. Dr. Currier has also led several efforts to expand the study of sex differences in treatment outcomes and to enhance research on women with HIV, specifically maternal health outcomes following interventions to reduce mother to child HIV transmission.
Yogan Pillay, National Department of Health, South Africa
Optimization, Effectiveness and Efficiency of Service Delivery: Integration of HIV and Health Services
Yogan Pillay is the Deputy Director-General for Health in South Africa. He is responsible for policy making, guiding implementation and monitoring of national programmes in HIV, TB and maternal, child and women's health. He is also currently facilitating the implementation of a national programme to re-engineer the primary health care system in South Africa. Dr. Pillay has a PhD in public health from Johns Hopkins University and has contributed to a large number of journal articles including co-authorship of papers on financing of HIV and AIDS programmes and drug resistant TB. He is a co-author of the Textbook of International Health: Global health in a Dynamic World